Dirk Thye
Chief Executive Officer at QUINCE THERAPEUTICS, INC.
Net worth: 710 124 $ as of 2024-04-29
Network origin in Dirk Thye first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
| Public Company | Pharmaceuticals: Other | 14 | |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.
12
| Extinct | Miscellaneous Commercial Services | 12 |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Agenovir Corp.
 Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Geom Therapeutics, Inc. operates as a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. The company is headquartered in San Francisco, CA.
1
| Extinct | Miscellaneous Commercial Services | 1 |
Inclin, Inc.
 Inclin, Inc. Miscellaneous Commercial ServicesCommercial Services Inclin, Inc. engages in a pharmaceuticals and biotechnology companies. It provides biometrics, clinical operations, strategic consulting, medical writing, quality assurance, drug safety, and medical monitoring services. The company was founded by Taylor Kilfoil and Arnold Wong in 1998 and is headquartered in San Mateo, CA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dirk Thye via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Compliance Officer Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Indiana University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Chairman Director/Board Member | |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman Chief Operating Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Director/Board Member | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chairman | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree | |
| Occidental College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Recida Therapeutics, Inc.
 Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| IGNYTA INC | Biotechnology | General Counsel Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
RightCare Solutions, Inc.
 RightCare Solutions, Inc. Packaged SoftwareTechnology Services Right Care Solutions, Inc. develops a discharge decision support platform. It offers risk assessment by flagging patients at risk for readmissions when admitted to the hospital. The solution also provides recommendations regarding post-acute care and community-based services for patients. The company was founded by Eric M. Heil and Kathyrn H. Bowles in 2011 and is headquartered in Horsham, PA. | Packaged Software | Director/Board Member Director/Board Member | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| AFFYMAX, INC. | Biotechnology | General Counsel Human Resources Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel General Counsel | |
| University of California, Irvine | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| Pepperdine University | College/University | Masters Business Admin Masters Business Admin |
Statistics
International
| United States | 50 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 37 |
| Consumer Services | 11 |
| Commercial Services | 2 |
| Government | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 317 |
| Corporate Officer/Principal | 165 |
| Independent Dir/Board Member | 84 |
| Chief Executive Officer | 63 |
| Chairman | 60 |
Most connected contacts
| Insiders | |
|---|---|
| Nina Kjellson | 49 |
| Eckard Weber | 46 |
| Patrick Heron | 42 |
| Una Ryan | 38 |
| Steven Elms | 37 |
| Robert Perez | 31 |
| Karen Smith | 29 |
| Dennis Podlesak | 27 |
| Timothy Franson | 26 |
| Christopher Lowe | 25 |
| Lowell E. Sears | 22 |
| Charles Ryan | 22 |
| David Lamond | 20 |
| Paul Truex | 17 |
| Matthew Wikler | 16 |
- Stock Market
- Insiders
- Dirk Thye
- Company connections